Oliceridine - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic sources for oliceridine and what is the scope of patent protection?
Oliceridine
is the generic ingredient in one branded drug marketed by Trevena and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Oliceridine has forty-nine patent family members in twenty-three countries.
Summary for oliceridine
| International Patents: | 49 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 26 |
| Clinical Trials: | 5 |
| Patent Applications: | 120 |
| What excipients (inactive ingredients) are in oliceridine? | oliceridine excipients list |
| DailyMed Link: | oliceridine at DailyMed |
Recent Clinical Trials for oliceridine
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Trevena Inc. | Phase 4 |
| University of Tennessee | Phase 4 |
| The Cleveland Clinic | Phase 3 |
US Patents and Regulatory Information for oliceridine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-002 | Oct 30, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-001 | Oct 30, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
| Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-003 | Oct 30, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-001 | Oct 30, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
| Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-002 | Oct 30, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
| Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-002 | Oct 30, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for oliceridine
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Israel | 228506 | ליגנדים של קולטן אופיואיד ותכשירי רוקחות המכילים אותם (Opioid receptor ligands and pharmaceutical compositions comprising them) | See Plans and Pricing |
| Japan | 2018048193 | オピオイド受容体リガンド並びにそれらの使用方法及び製造方法 (OPIOID RECEPTOR LIGANDS AND METHODS OF USING AND MAKING THE SAME) | See Plans and Pricing |
| World Intellectual Property Organization (WIPO) | 2012129495 | See Plans and Pricing | |
| Canada | 2830742 | OXANES SUBSTITUES COMME LIGANDS DE RECEPTEUR OPIOIDE ET METHODES D'UTILISATION ET DE FABRICATION ASSOCIEES (SUBSTITUTED OXANES AS OPIOID RECEPTOR LIGANDS AND METHODS OF USING AND MAKING SAME) | See Plans and Pricing |
| Japan | 2016155843 | オピオイド受容体リガンド並びにそれらの使用方法及び製造方法 (OPIOID RECEPTOR LIGANDS AND METHODS OF USING AND MAKING THE SAME) | See Plans and Pricing |
| Slovenia | 2688403 | See Plans and Pricing | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
